Testosterone therapy plus lifestyle intervention was tied to a larger improvement in sexual desire than lifestyle intervention alone among older men with impaired glucose tolerance, according to a secondary analysis of the T4DM trial.As Healio previously reported, the T4DM trial randomly assigned 1,007 men aged 50 to 74 years with a waist circumference of 95 cm or more and with IGT or newly diagnosed type 2 diabetes to 1,000 mg testosterone undecanoate (Reandron, Bayer) every 3 months or placebo for 2 years. Men receiving testosterone had a greater decline in 2-hour glucose than those in the
Read More